The aim of the study is to observe prospectively the possibility of lowering the cancer risk among BRCA1 carriers by optimizing selenium concentration in diet/organism. Results of studies performed in several centres, particularly of our own search, are strongly indicating on potential of decreasing breast/ovarian cancer risk among carriers by optimization of selenium concentration in the body. Studies will be performed on group of 1500 BRCA1 carriers. Cohort will be recruited during the first 6 months of the project. Mean length of follow-up will be 3 yrs. From all females serum will be collected for selenium analyses-at the beginning and, then, every 6 months. Participants will receive the list of products with selenium concentration estimated according to literature data and, additionally, information about e-store (http://www.dietaantyrakowa.pl) specialized in distribution of food products with defined amount of selenium. Information on optimal selenium concentration according to existing data will be provided also. It is expected that among ~750 carriers following recommended diet changes 38 cancers will be diagnosed and among the others ~750-60. The difference between groups will be statistically significant with p=0.0278. If necessary, investigation will be extended.
. 2012 Jan 12;10(Suppl 1):A11. doi: 10.1186/1897-4287-10-S1-A11
Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
J Lubiński
1,✉, T Huzarski
1, A Jakubowska
1, J Gronwald
1, K Jaworska
1, M Muszyńska
1, G Sukiennicki
1, K Durda
1, C Cybulski
1, T Dębniak
1, A Tołoczko
1, O Oszurek
1, P Serrano-Fernandez
1, R Scott
1, S Narod
1
J Lubiński
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by J Lubiński
T Huzarski
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by T Huzarski
A Jakubowska
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by A Jakubowska
J Gronwald
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by J Gronwald
K Jaworska
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by K Jaworska
M Muszyńska
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by M Muszyńska
G Sukiennicki
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by G Sukiennicki
K Durda
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by K Durda
C Cybulski
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by C Cybulski
T Dębniak
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by T Dębniak
A Tołoczko
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by A Tołoczko
O Oszurek
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by O Oszurek
P Serrano-Fernandez
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by P Serrano-Fernandez
R Scott
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by R Scott
S Narod
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
Find articles by S Narod
1International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
✉
Corresponding author.
Supplement
Annual Conference on Hereditary Cancers 2010
Jan Lubiñski
Conference
10-11 December 2010
Annual Conference on Hereditary Cancers 2010
Szczecin, Poland
Collection date 2012.
Copyright ©2012 Lubiński et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC3287431
